A single injection of an experimental monoclonal antibody called L9LS prevented malaria infection in children in Mali. (IMAGE)

NIH/National Institute of Allergy and Infectious Diseases

A single injection of an experimental monoclonal antibody called L9LS prevented malaria infection in children in Mali.

Caption

A single injection of an experimental monoclonal antibody called L9LS prevented malaria infection in children in Mali. L9LS binds to and neutralizes “sporozoites,” the form of the malaria parasite transmitted by mosquitoes that invades the liver to initiate infection.

Credit

NIH

Usage Restrictions

No restrictions.

License

Public Domain

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.